{"article_title": "Pfizer Sweetens Bid for AstraZeneca", "article_keywords": ["talksthey", "valued", "rulesnew", "takeover", "offer", "pfizer", "bid", "rebuffed", "british", "yorkbased", "astrazeneca", "reject", "sweetens"], "article_url": "http://www.wsj.com/articles/SB10001424052702303468704579570100099651082", "article_text": "Pfizer Inc. said it made a final offer for AstraZeneca PLC valued at about $120 billion, after the British pharmaceutical company rebuffed its latest effort to enter takeover talks.\n\n\"They can either accept it or reject it,\" Pfizer Chairman and Chief Executive Ian Read said Sunday in an interview. \"They have until the 26th of May\" under British takeover rules.\n\nNew York-based Pfizer said its new offer...", "article_metadata": {"article.template": "snippet", "article.created": "2014-05-18T17:48:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "Pfizer sweetened a takeover offer for AstraZeneca to about $120 billion Sunday, in a final effort to bring the British drug giant to the negotiating table.", "title": "Pfizer Sweetens Bid for AstraZeneca", "image": {"src": "https://si.wsj.net/public/resources/images/MK-CM467_PHIZER_G_20140518201429.jpg", "alt": "Pfizer sweetens bid for British rival AstraZeneca", "identifier": "https://si.wsj.net/public/resources/images/MK-CM467_PHIZER_D_20140518201429.jpg"}, "creator": "@jonathanrockoff", "site": "@WSJ", "card": "summary_large_image"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10001424052702303468704579570100099651082&headline=Pfizer%20sweetens%20bid%20for%20British%20rival%20AstraZeneca&weburl=http://www.wsj.com/articles/SB10001424052702303468704579570100099651082"}}, "page.site.product": "WSJ", "keywords": "Pfizer,PFE,AstraZeneca,AZN.LN,Ian Read,ownership changes,acquisitions,mergers,takeovers,contracts,orders,non-governmental contracts,management issues,corporate actions,corporate,industrial news,pharmaceuticals,health care,life sciences", "news_keywords": "Pfizer,PFE,AstraZeneca,AZN.LN,Ian Read,ownership changes,acquisitions,mergers,takeovers,contracts", "article.headline": "Pfizer sweetens bid for British rival AstraZeneca", "cXenseParse": {"candybar": {"image": "https://si.wsj.net/public/resources/images/MK-CM467_PHIZER_E_20140518201429.jpg"}, "poptart": {"image": "https://si.wsj.net/public/resources/images/MK-CM467_PHIZER_D_20140518201429.jpg"}}, "description": "Pfizer sweetened a takeover offer for AstraZeneca to about $120 billion Sunday, in a final effort to bring the British drug giant to the negotiating table.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10001424052702303468704579570100099651082&headline=Pfizer%20sweetens%20bid%20for%20British%20rival%20AstraZeneca&weburl=http://www.wsj.com/articles/SB10001424052702303468704579570100099651082", "user.type": "nonsubscriber", "testkeys": "C", "article.page": "Business", "article.summary": "Pfizer sweetened a takeover offer for AstraZeneca to about $120 billion Sunday, in a final effort to bring the British drug giant to the negotiating table.", "page.site": "wsj", "page.content.format": "responsive", "article.published": "2014-05-19T00:37:00.000Z", "dj.asn": "i-e963", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"publisher": "https://www.facebook.com/wsj", "author": "https://www.facebook.com/www.facebook.com/shayndi", "embed_count": 1, "word_count": 917, "internal_link_count": 3, "image_count": 1}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "Pfizer sweetened a takeover offer for AstraZeneca to about $120 billion Sunday, in a final effort to bring the British drug giant to the negotiating table.", "title": "Pfizer Sweetens Bid for AstraZeneca", "url": "http://www.wsj.com/articles/SB10001424052702303468704579570100099651082", "image": {"width": 553, "identifier": "https://si.wsj.net/public/resources/images/MK-CM467_PHIZER_G_20140518201429.jpg", "height": 369}, "locale": "en_US", "type": "article"}, "author": "Jonathan D. Rockoff and Shayndi Raice", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Pfizer Said to Be Planning to Make Sweetened Bid for AstraZeneca", "article.type": "Business", "article.id": "SB10001424052702303468704579570100099651082", "user.exp": "default", "article.updated": "2014-05-19T00:37:00.000Z"}, "_id": "\"57477af36914bd0286fcaeb3\"", "article_summary": "New York-based Pfizer said its new offer...\n\"They can either accept it or reject it,\" Pfizer Chairman and Chief Executive Ian Read said Sunday in an interview.\nPfizer Inc. said it made a final offer for AstraZeneca PLC valued at about $120 billion, after the British pharmaceutical company rebuffed its latest effort to enter takeover talks.\n\"They have until the 26th of May\" under British takeover rules."}